a public good project by the
Synthesis
Company
of California

© 2026

R. Aller | doi.page

0 works0 citations0 h-index

R. Aller

Centro de Investigación en Red en Enfermedades Cardiovasculares(ES)Hospital Clínico Universitario de Valladolid(ES)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Diet and metabolism studies, Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Diet, Metabolism, and Disease

Most-Cited Works

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.(2011)
→ Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?(2021)193 cited
→ Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease(2021)183 cited
→ Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis(2019)176 cited
→ The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease(2020)130 cited
→ The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats(2007)117 cited

Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.

(2015)

→ Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica(2018)109 cited

→ Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2(2005)107 cited

→ The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity(2018)104 cited